The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 6, 2004, Pages 595-614

  Awadzi, K ^a   Edwards, G ^b,c   Opoku, N O ^a   Ardrey, A E ^b   Favager, S ^b   Addy, E T ^a   Attah, S K ^a   Yamuah, L K ^d   Quartey, B T ^a  

^a Hohoe Hospital   (Ghana)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; AMINOTRANSFERASE; BELLADONNA ALKALOID; CHLOROQUINE; CHLORPHENIRAMINE; FLUORESCEIN SODIUM; IVERMECTIN; LEVAMISOLE; MAGNESIUM TRISILICATE; PARACETAMOL;

ABDOMINAL PAIN; ADULT; AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE PAIN; FEMALE; FEVER; HEADACHE; HEART PALPITATION; HISTOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; MICROFILARIA; MYALGIA; NAUSEA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATHOGENESIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RASH; SINUS BRADYCARDIA; URTICARIA; VOMITING;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTICESTODAL AGENTS; ANTINEMATODAL AGENTS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IVERMECTIN; LEVAMISOLE; MALE; MICROFILARIA; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; TREATMENT OUTCOME;

ATROPA BELLADONNA; NEMATODA; ONCHOCERCA; ONCHOCERCA VOLVULUS;

EID: 4544240272     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349804225021370     Document Type: Article

References (31)

1. Ali, M. M. M., Mukhtar, M. M., Baraka, O. Z., Homeida, M. M. A., Kheir, M. M. & Mackenzie, C. D. (2002). Immunocompetence may be important in the effectiveness of Mectizan® (ivermectin) in the treatment of human onchocerciasis. Acta Tropica, 84, 49-53.
2. Ali, M. M., Baraka, O. Z., Abdelrahman, S. I., Sulaiman, S. M., Williams, J. F., Homeida, M. M. & Mackenzie, C. D. (2003). Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. Journal of Infectious Diseases, 187, 714-717.
3. Anon. (1999). Guidance for Industry. In Vivo Drug Metabolism/drug Interaction Studies - Study Design, Data Analysis, and Recommendations for Dosing and Labeling. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
4. Awadzi, K. (1980). The chemotherapy of onchocerciasis. II. Quantitation of the clinical reaction to microfilaricides. Annals of Tropical Medicine and Parasitology, 74, 189-197.
5. Awadzi, K., Schulz-Key, H., Howells, R. E., Haddock, D. R. W. & Gilles, H. M. (1982). The chemotherapy of onchocerciasis. VIII. Levamisole and its combination with the benzimidazoles. Annals of Tropical Medicine and Parasitology, 76, 459-473.
6. Awadzi, K., Dadzie, K. Y., de Sole, G. & Remme, J. (1990a). Reactions to ivermectin treatment in onchocerciasis patients. Acta Leidensia, 59, 193-199.
7. Awadzi, K., Schulz Key, H., Edwards, G., Breckenridge, A., Orme, M. & Gilles, H. (1990b). The chemotherapy of onchocerciasis. XIV. Studies with mebendazole citrate. Tropical Medicine and Parasitology, 41, 383-386.
8. Awadzi, K., Hero, M., Opoku, O., Buttner, D. W. & Gilles, H. M. (1991). The chemotherapy of onchocerciasis. XV. Studies with albendazole. Tropical Medicine and Parasitology, 42, 356-360.
9. Awadzi, K., Hero, M., Opoku, N. O., Buttner, D. W., Coventry, P. A., Prime, M. A., Orme, M. L. & Edwards, G. (1994). The chemotherapy of onchocerciasis. XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Tropical Medicine and Parasitology, 45, 203-208.
10. Awadzi, K., Addy, E. T., Opoku, N. O., Plenge-Bonig, A. & Buttner, D. W. (1995a). The chemotherapy of onchocerciasis. XX. Ivermectin in combination with albendazole. Tropical Medicine and Parasitology, 46, 213-220.
11. Awadzi, K., Opoku, N. O., Addy, E. T. & Quartey, B. T. (1995b). The chemotherapy of onchocerciasis. XIX. The clinical and laboratory tolerance of high dose ivermectin. Tropical Medicine and Parasitology, 46, 131-137.
12. Awadzi, K., Opoku, N. O., Attah, S. K., Addy, E. T., Duke, B. O., Nyame, P. K. & Kshirsagar, N. A. (1997). The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Annals of Tropical Medicine and Parasitology, 91, 281-296.
13. Awadzi, K., Attah, S. K., Addy, E. T., Opoku, N. O. & Quartey, B. T. (1999). The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 189-194.
14. Awadzi, K., Edwards, G., Duke, B. O. L., Opoku, N. O., Attah, S. K., Addy, E. T., Ardrey, A. E. & Quartey, B. T. (2003). The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus. Annals of Tropical Medicine and Parasitology, 97, 165-178.
15. Chavasse, D. C., Post, R. J., Lemoh, P. A. & Whitworth, J. A. (1992). The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Tropical Medicine and Parasitology, 43, 256-262.
16. Duke, B. O., Zea-Flores, G., Castro, J., Cupp, E. W. & Munoz, B. (1992). Effects of three-month doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene, 46, 189-194.
17. Edwards, G., Dingsdale, A., Helsby, N., Orme, M. L. & Breckenridge, A. M. (1988). Relative systemic availability of ivermectin after administration as capsule, tablet and oral solution. European Journal of Clinical Pharmacology, 35, 681-684.
18. Gardon, J., Boussinesq, M., Kamgno, J., Gardon-Wendel, N., Demanga, N. & Duke, B. O. (2002). Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet, 360, 203-210.
19. Hero, M., Bird, A. C. & Awadzi, K. (1992). Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis. Eye, 6, 93-96.
20. Hoaksey, P. E., Awadzi, K., Ward, S. A., Coventry, P. A., Orme, M. L. & Edwards, G. (1991). Rapid and sensitive method for the determination of albendazole and albendazole sulphoxide in biological fluids. Journal of Chromatography, 566, 244-249.
21. Klager, S. L., Whitworth, J. A. & Downham, M. D. (1996). Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Tropical Medicine and International Health, 1, 581-589.
22. Kouassi, E., Caille, G., Lariviere, L. & Vezina, M. (1986). Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharmaceutics and Drug Disposition, 7, 71-89.
23. Kwei, G. Y., Alvaro, R. F., Chen, Q., Jenkins, H. J., Hop, C. E. A. C., Keohane, C. A., Ly, V. T., Strauss, J. R., Wang, R. W., Wang, Z., Pippert, T. R. & Umbenhauer, D. R. (1999). Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in MDRA1A p-glycoprotein. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 27, 581-587.
24. Merino, G., Alvarez, A. I., Prieto, J. G. & Kim, R. B. (2002). The anthelminthic agent albendazole does not interact with p-glycoprotein. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 30, 365-369.
25. Ottesen, E. A. (1995). Immune responsiveness and the pathogenesis of human onchocerciasis. Journal of Infectious Diseases, 171, 659-671.
26. Rawden, H. C. (1999). An investigation of potential chemotherapeutic drug combinations with albendazole for the treatment of Echinococcus infection. Ph.D. thesis, Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, U.K.
27. Rawden, H. C., Kokwaro, G. O., Ward, S. A. & Edwards, G. (2000). Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. British Journal of Clinical Pharmacology, 49, 313-322.
28. Renoux, G. (1980). The general immunopharmacology of levamisole. Drugs, 20, 89-99.
29. Taylor, H. R., Awadzi, K., George, T., Schulz-Key, H. & Murphy, R. P. (1985). Fluorescein angiographic studies of mebendazole treatment for onchocerciasis. Tropical Medicine and Parasitology, 36, 7-11.
30. World Health Organization (1987). WHO Expert Committee on Onchocerciasis. Third Report. Technical Report Series No. 752. Geneva: WHO.
31. World Health Organization (1995). Onchocerciasis and its Control. Report of a WHO Expert Committee on Onchocerciasis Control. Technical Report Series No. 852. Geneva: WHO.